Hi Flectional Thank you for sharing your research. Be awesome now that this redomicile period is finalizing for shareholders and we can get back to the pharmaceutical pathway news flow and discussions. Massive potential Incannex has when compared to peers. Lots happening in the M&A space. IMO the market is waiting on data. As potential new is replaced by tangible news (near term) with our 3 lead assets and more liquidity is available soon this tight elastic bank effect the SP is experiencing now will let go. A quality Cornerstone Venture Capital Provider or Strategic Industry Partnership to fund our 3 leading compounds to registration potential would show confidence.
